Profil
Deborah Palestrant is currently Partner & Executive Chairman at 5AM Venture Management LLC since 2018.
Former roles include Senior Director-Business Development & Strategy at Editas Medicine, Inc., Independent Director at Latigo Biotherapeutics, Inc., Researcher at The Scripps Research Institute, Senior Associate at Third Rock Ventures LLC from 2010 to 2013, and Vice President-Development & Strategy at Relay Therapeutics, Inc. from 2017 to 2018.
Education includes a doctorate from The Trustees of Columbia University in The City of New York conferred in 2000, an undergraduate degree from the University of California, Los Angeles in 1995, and an MBA from Northeastern University in 2009.
Postes actifs de Deborah Palestrant
| Sociétés | Poste | Début |
|---|---|---|
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Président | 01/11/2018 |
Anciens postes connus de Deborah Palestrant
| Sociétés | Poste | Fin |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2018 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Analyste en capital-investissement | 01/12/2013 |
| LATIGO BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Deborah Palestrant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
















